Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Right Brain Language Function and Academic Honesty.

Holodny AI.

Brain Connect. 2018 Aug;8(6):319-320. doi: 10.1089/brain.2018.29000.aih. No abstract available.

PMID:
30124343
2.

Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer.

Chen BT, Jin T, Patel SK, Ye N, Sun CL, Ma H, Rockne RC, Root JC, Saykin AJ, Ahles TA, Holodny AI, Prakash N, Mortimer J, Waisman J, Yuan Y, Li D, Somlo G, Vazquez J, Levi A, Tan H, Yang R, Katheria V, Hurria A.

Breast Cancer Res Treat. 2018 Aug 7. doi: 10.1007/s10549-018-4911-y. [Epub ahead of print]

PMID:
30088178
3.

Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study.

Chen BT, Ghassaban K, Jin T, Patel SK, Ye N, Sun CL, Kim H, Rockne RC, Mark Haacke E, Root JC, Saykin AJ, Ahles TA, Holodny AI, Prakash N, Mortimer J, Waisman J, Yuan Y, Somlo G, Li D, Yang R, Tan H, Katheria V, Morrison R, Hurria A.

Magn Reson Imaging. 2018 Dec;54:218-224. doi: 10.1016/j.mri.2018.07.016. Epub 2018 Aug 2.

PMID:
30076946
4.

Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.

Hatzoglou V, Oh JH, Buck O, Lin X, Lee M, Shukla-Dave A, Young RJ, Peck KK, Vachha B, Holodny AI, Grommes C.

J Neurooncol. 2018 Aug 2. doi: 10.1007/s11060-018-2960-z. [Epub ahead of print]

PMID:
30073640
5.
6.

Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients.

Miloushev VZ, Granlund KL, Boltyanskiy R, Lyashchenko SK, DeAngelis LM, Mellinghoff IK, Brennan CW, Tabar V, Yang TJ, Holodny AI, Sosa RE, Guo YW, Chen AP, Tropp J, Robb F, Keshari KR.

Cancer Res. 2018 Jul 15;78(14):3755-3760. doi: 10.1158/0008-5472.CAN-18-0221. Epub 2018 May 16.

PMID:
29769199
7.

Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.

Chen BT, Sethi SK, Jin T, Patel SK, Ye N, Sun CL, Rockne RC, Haacke EM, Root JC, Saykin AJ, Ahles TA, Holodny AI, Prakash N, Mortimer J, Waisman J, Yuan Y, Somlo G, Li D, Yang R, Tan H, Katheria V, Morrison R, Hurria A.

Breast Cancer Res. 2018 May 2;20(1):38. doi: 10.1186/s13058-018-0965-3.

8.

Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1-Weighted Dynamic Contrast-Enhanced MRI.

Morales KA, Arevalo-Perez J, Peck KK, Holodny AI, Lis E, Karimi S.

AJNR Am J Neuroradiol. 2018 May;39(5):968-973. doi: 10.3174/ajnr.A5630. Epub 2018 Apr 12.

PMID:
29650780
9.
10.

Diffusion Tensor Imaging Shows Corpus Callosum Differences between High-Grade Gliomas and Metastases.

Cho NS, Jenabi M, Arevalo-Perez J, Brennan N, Young RJ, Karimi S, Holodny AI, Peck KK.

J Neuroimaging. 2018 Mar;28(2):199-205. doi: 10.1111/jon.12478. Epub 2017 Oct 24.

PMID:
29064137
11.

T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma.

Santos P, Peck KK, Arevalo-Perez J, Karimi S, Lis E, Yamada Y, Holodny AI, Lyo J.

AJNR Am J Neuroradiol. 2017 Nov;38(11):2210-2216. doi: 10.3174/ajnr.A5383. Epub 2017 Sep 14.

12.

A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases.

Kumar KA, Peck KK, Karimi S, Lis E, Holodny AI, Bilsky MH, Yamada Y.

Technol Cancer Res Treat. 2017 Jan 1:1533034617705715. doi: 10.1177/1533034617705715. [Epub ahead of print]

13.

Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.

Hatzoglou V, Tisnado J, Mehta A, Peck KK, Daras M, Omuro AM, Beal K, Holodny AI.

Cancer Med. 2017 Apr;6(4):761-767. doi: 10.1002/cam4.1046. Epub 2017 Mar 17.

14.

Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.

Lis E, Saha A, Peck KK, Zatcky J, Zelefsky MJ, Yamada Y, Holodny AI, Bilsky MH, Karimi S.

Neurosurg Focus. 2017 Jan;42(1):E9. doi: 10.3171/2016.9.FOCUS16378.

15.

Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.

Lin X, Lee M, Buck O, Woo KM, Zhang Z, Hatzoglou V, Omuro A, Arevalo-Perez J, Thomas AA, Huse J, Peck K, Holodny AI, Young RJ.

AJNR Am J Neuroradiol. 2017 Mar;38(3):485-491. doi: 10.3174/ajnr.A5023. Epub 2016 Dec 8.

16.

Comparison of compressed sensing diffusion spectrum imaging and diffusion tensor imaging in patients with intracranial masses.

Young RJ, Tan ET, Peck KK, Jenabi M, Karimi S, Brennan N, Rubel J, Lyo J, Shi W, Zhang Z, Prastawa M, Liu X, Sperl JI, Fatovic R, Marinelli L, Holodny AI.

Magn Reson Imaging. 2017 Feb;36:24-31. doi: 10.1016/j.mri.2016.10.001. Epub 2016 Oct 11.

18.

A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.

Pietanza MC, Litvak AM, Varghese AM, Krug LM, Fleisher M, Teitcher JB, Holodny AI, Sima CS, Woo KM, Ng KK, Won HH, Berger MF, Kris MG, Rudin CM.

Lung Cancer. 2016 Sep;99:23-30. doi: 10.1016/j.lungcan.2016.04.014. Epub 2016 Apr 26.

19.

Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease.

Diamond EL, Hatzoglou V, Patel S, Abdel-Wahab O, Rampal R, Hyman DM, Holodny AI, Raj A.

Orphanet J Rare Dis. 2016 Aug 2;11(1):109. doi: 10.1186/s13023-016-0490-3.

20.

Altered Resting-State Functional Connectivity in the Hand Motor Network in Glioma Patients.

Mallela AN, Peck KK, Petrovich-Brennan NM, Zhang Z, Lou W, Holodny AI.

Brain Connect. 2016 Aug 22. [Epub ahead of print]

PMID:
27457676
21.

Brain Tumors: The Influence of Tumor Type and Routine MR Imaging Characteristics at BOLD Functional MR Imaging in the Primary Motor Gyrus.

Fraga de Abreu VH, Peck KK, Petrovich-Brennan NM, Woo KM, Holodny AI.

Radiology. 2016 Dec;281(3):876-883. Epub 2016 Jul 7.

22.

Second-opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care.

Hatzoglou V, Omuro AM, Haque S, Khakoo Y, Ganly I, Oh JH, Shukla-Dave A, Fatovic R, Gaal J, Holodny AI.

Cancer. 2016 Sep 1;122(17):2708-14. doi: 10.1002/cncr.30083. Epub 2016 May 24.

23.

Hyperpolarization MRI: Preclinical Models and Potential Applications in Neuroradiology.

Miloushev VZ, Keshari KR, Holodny AI.

Top Magn Reson Imaging. 2016 Feb;25(1):31-7. doi: 10.1097/RMR.0000000000000076. Review.

24.

Cortical Plasticity in the Setting of Brain Tumors.

Fisicaro RA, Jost E, Shaw K, Brennan NP, Peck KK, Holodny AI.

Top Magn Reson Imaging. 2016 Feb;25(1):25-30. doi: 10.1097/RMR.0000000000000077. Review.

25.

fMRI activation in the middle frontal gyrus as an indicator of hemispheric dominance for language in brain tumor patients: a comparison with Broca's area.

Dong JW, Brennan NM, Izzo G, Peck KK, Holodny AI.

Neuroradiology. 2016 May;58(5):513-20. doi: 10.1007/s00234-016-1655-4. Epub 2016 Feb 5.

26.

Nonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative Factors.

Hatzoglou V, Karimi S, Diamond EL, Lis E, Krol G, Holodny AI, Young RJ.

Neurohospitalist. 2016 Jan;6(1):24-8. doi: 10.1177/1941874415591702.

27.

Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.

Arevalo-Perez J, Kebede AA, Peck KK, Diamond E, Holodny AI, Rosenblum M, Rubel J, Gaal J, Hatzoglou V.

J Neuroimaging. 2016 May;26(3):366-71. doi: 10.1111/jon.12320. Epub 2015 Dec 26.

28.

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.

de la Fuente MI, Young RJ, Rubel J, Rosenblum M, Tisnado J, Briggs S, Arevalo-Perez J, Cross JR, Campos C, Straley K, Zhu D, Dong C, Thomas A, Omuro AA, Nolan CP, Pentsova E, Kaley TJ, Oh JH, Noeske R, Maher E, Choi C, Gutin PH, Holodny AI, Yen K, DeAngelis LM, Mellinghoff IK, Thakur SB.

Neuro Oncol. 2016 Feb;18(2):283-90. doi: 10.1093/neuonc/nov307. Epub 2015 Dec 20.

29.

Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.

Zhang M, Gulotta B, Thomas A, Kaley T, Karimi S, Gavrilovic I, Woo KM, Zhang Z, Arevalo-Perez J, Holodny AI, Rosenblum M, Young RJ.

Neuro Oncol. 2016 May;18(5):735-43. doi: 10.1093/neuonc/nov268. Epub 2015 Nov 3.

30.

T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status.

Arevalo-Perez J, Thomas AA, Kaley T, Lyo J, Peck KK, Holodny AI, Mellinghoff IK, Shi W, Zhang Z, Young RJ.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2256-61. doi: 10.3174/ajnr.A4484. Epub 2015 Sep 3.

31.

Corpus Callosum Diffusion and Language Lateralization in Patients with Brain Tumors: A DTI and fMRI Study.

Tantillo G, Peck KK, Arevalo-Perez J, Lyo JK, Chou JF, Young RJ, Brennan NP, Holodny AI.

J Neuroimaging. 2016 Mar-Apr;26(2):224-31. doi: 10.1111/jon.12275. Epub 2015 Aug 10.

32.

Identification of the Corticobulbar Tracts of the Tongue and Face Using Deterministic and Probabilistic DTI Fiber Tracking in Patients with Brain Tumor.

Jenabi M, Peck KK, Young RJ, Brennan N, Holodny AI.

AJNR Am J Neuroradiol. 2015 Nov;36(11):2036-41. doi: 10.3174/ajnr.A4430. Epub 2015 Aug 6.

33.

Vascular Reactivity Maps in Patients with Gliomas Using Breath-Holding BOLD fMRI.

Iranmahboob A, Peck KK, Brennan NP, Karimi S, Fisicaro R, Hou B, Holodny AI.

J Neuroimaging. 2016 Mar-Apr;26(2):232-9.

34.

Pre-operative fMRI localization of the supplementary motor area and its relationship with postoperative speech deficits.

Lyo JK, Arevalo-Perez J, Petrovich Brennan N, Peck KK, Holodny AI.

Neuroradiol J. 2015 Jun;28(3):281-8. doi: 10.1177/1971400915589681.

35.

Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.

Jung BC, Arevalo-Perez J, Lyo JK, Holodny AI, Karimi S, Young RJ, Peck KK.

J Neuroimaging. 2016 Mar-Apr;26(2):240-6. doi: 10.1111/jon.12281. Epub 2015 Aug 3.

36.

Challenges in Identifying the Foot Motor Region in Patients with Brain Tumor on Routine MRI: Advantages of fMRI.

Fisicaro RA, Jiao RX, Stathopoulos C, Petrovich Brennan NM, Peck KK, Holodny AI.

AJNR Am J Neuroradiol. 2015 Aug;36(8):1488-93. doi: 10.3174/ajnr.A4292. Epub 2015 Apr 16.

37.

Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.

Arevalo-Perez J, Peck KK, Young RJ, Holodny AI, Karimi S, Lyo JK.

J Neuroimaging. 2015 Sep-Oct;25(5):792-8. doi: 10.1111/jon.12239. Epub 2015 Apr 13.

38.

Differentiating benign from malignant vertebral fractures using T1 -weighted dynamic contrast-enhanced MRI.

Arevalo-Perez J, Peck KK, Lyo JK, Holodny AI, Lis E, Karimi S.

J Magn Reson Imaging. 2015 Oct;42(4):1039-47. doi: 10.1002/jmri.24863. Epub 2015 Feb 5.

39.

Use of CT perfusion to discriminate between brain metastases from different primaries.

Dolgushin MB, Pronin IN, Holodny EA, Fadeeva LM, Holodny AI, Kornienko VN.

Clin Imaging. 2015 Jan-Feb;39(1):9-14. doi: 10.1016/j.clinimag.2014.10.006. Epub 2014 Oct 16.

PMID:
25457544
40.

Blood oxygen level dependent functional magnetic resonance imaging for presurgical planning.

Gabriel M, Brennan NP, Peck KK, Holodny AI.

Neuroimaging Clin N Am. 2014 Nov;24(4):557-71. doi: 10.1016/j.nic.2014.07.003. Epub 2014 Nov 1. Review.

PMID:
25441500
41.

Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.

Zauderer MG, Drilon A, Kadota K, Huberman K, Sima CS, Bergagnini I, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Riely GJ, Kris MG, Krug LM, Pietanza MC.

Lung Cancer. 2014 Nov;86(2):237-40. doi: 10.1016/j.lungcan.2014.08.007. Epub 2014 Aug 17.

42.

Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.

Saha A, Peck KK, Lis E, Holodny AI, Yamada Y, Karimi S.

Spine (Phila Pa 1976). 2014 Nov 15;39(24):E1433-40. doi: 10.1097/BRS.0000000000000570.

43.

Probabilistic fiber tracking of the language and motor white matter pathways of the supplementary motor area (SMA) in patients with brain tumors.

Jenabi M, Peck KK, Young RJ, Brennan N, Holodny AI.

J Neuroradiol. 2014 Dec;41(5):342-9. doi: 10.1016/j.neurad.2013.12.001. Epub 2013 Dec 28.

44.

Resection of glioma in an fMRI-defined "split" Broca's area.

Kim JH, Amankulor NM, Peck KK, Brennan N, Gutin PH, Holodny AI.

Neurocase. 2014;20(5):481-6. doi: 10.1080/13554794.2013.826678. Epub 2013 Aug 13.

PMID:
23937303
45.

Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy.

Chu S, Karimi S, Peck KK, Yamada Y, Lis E, Lyo J, Bilsky M, Holodny AI.

Spine (Phila Pa 1976). 2013 Oct 15;38(22):E1418-24. doi: 10.1097/BRS.0b013e3182a40838.

46.

Clinical applications of functional MR imaging.

Belyaev AS, Peck KK, Brennan NM, Holodny AI.

Magn Reson Imaging Clin N Am. 2013 May;21(2):269-78. doi: 10.1016/j.mric.2012.12.001. Epub 2013 Mar 5. Review.

PMID:
23642553
47.

Diffusion-weighted imaging to assess treatment response in a child with trilateral retinoblastoma.

Bonci GA, Rosenblum MK, Gilheeney SW, Dunkel IJ, Holodny AI.

Pediatr Radiol. 2013 Sep;43(9):1231-4. doi: 10.1007/s00247-013-2662-9. Epub 2013 Mar 12.

PMID:
23478798
48.

Diffusion tensor tractography of the arcuate fasciculus in patients with brain tumors: Comparison between deterministic and probabilistic models.

Li Z, Peck KK, Brennan NP, Jenabi M, Hsu M, Zhang Z, Holodny AI, Young RJ.

J Biomed Sci Eng. 2013 Feb;6(2):192-200.

49.

Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis.

Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ.

J Neuroimaging. 2014 Mar-Apr;24(2):161-6. doi: 10.1111/j.1552-6569.2012.00767.x. Epub 2012 Dec 28.

50.

Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients.

Hatzoglou V, Ulaner GA, Zhang Z, Beal K, Holodny AI, Young RJ.

Clin Imaging. 2013 May-Jun;37(3):451-7. doi: 10.1016/j.clinimag.2012.08.008. Epub 2012 Oct 12.

Supplemental Content

Loading ...
Support Center